• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks

Cancer Drug Costs on the Rise

Morag Mcgreevey
Jul. 17, 2015 01:33PM PST
Pharmaceutical Investing

California Association of Health Plans released a two-page infographic concerning the increasing cost of cancer drugs.

California Association of Health Plans released a two-page infographic concerning the increasing cost of cancer drugs.
According to the infographic:

More than one million Californians have a history of cancer, and 172,000 new cases will be diagnosed in California this year. Medical advancements have saved millions of lives and increased the quality of life for patients.
Costs are escalating with many medications now introduced at over $100,000 a year. Policy-makers, players, physicians, and consumers are increasingly concerned about the rising price for cancer therapies and are questioning the link between sky-high prices and the relative value some of these new medications provide.

Click here to view the infographic on the California Association of Health Plans website.

market-news
The Conversation (0)

Go Deeper

AI Powered
Large pharmaceutical pill with gold dollar sign in the middle. Stock tickers and charts in the background.

Top 5 Small-cap Pharma Stocks (Updated January 2026)

Scientist pouring blue liquid from a test tube into a flask in a lab.

Biotech Market Forecast: Top Trends for Biotech in 2026

Latest News

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES